Discontinuation report ONDANSETRON INJECTION, USP
Report ID | 160323 |
Drug Identification Number | 02390019 |
Brand name | ONDANSETRON INJECTION, USP |
Common or Proper name | ONDANSETRON INJECTION, USP |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2ML 5VL, 4ML 5VL |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-05-09 |
Remaining supply date | 2022-05-09 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 130644. Last lot 7008750 Expiry February-28-2022. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-05-11 | English | Compare |
v2 | 2022-05-11 | French | Compare |
Showing 1 to 2 of 2